Medicaid

Commentary

Expand Medicaid? Democrats’ plan would increase waste, fraud and debt

If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Business & Economics

Basic Income Guarantees Would ‘Warehouse’ Poor, Not Propel Them

As Americans struggle to recover from a deep recession fueled by the COVID-19 crisis, and respond in horror to the violence in many communities following the death of George Floyd, economic inequality and lack of opportunity have risen to the top of the political discussion. Liberal voices like House Speaker ...
Commentary

Do coronavirus numbers show bias in health care? This study’s results will surprise you

African-Americans make up 12.4 percent of the population but have accounted for 23.8 percent of the nation’s COVID-19 deaths, as of June 23. This disparity has gained considerable attention in light of the protests sweeping the country. But the situation is more complicated than it appears. According to a working ...
Commentary

Democrats’ Obamacare Bailout Could Extend The Pandemic

This week, the House of Representatives is set to vote on legislation designed to “stabilize” Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic crisis. But the legislation would ...
Climate Change

Biden’s Mask Of Moderation Has Finally Slipped

Presumptive Democratic presidential nominee Joe Biden pitches himself to American voters as a reasonable and pragmatic centrist. But he’s stocked his campaign team with some of the Democratic party’s most prominent—and extreme—left-wingers. Last month, Biden announced the creation of several policy task forces designed to bring the party together. Those task ...
Commentary

COVID-19 Reveals The Power Of Deregulation

One of the most effective policy responses to COVID-19 thus far has not been a new government program or infusion of federal funding. Rather, it’s been the deliberate effort by the Trump administration to pare back regulations impeding access to health care. That work must continue after the pandemic passes. ...
Commentary

The coronavirus recession is no excuse for Medicaid expansion

House Democrats are looking to funnel billions of dollars into state Medicaid programs through the HEROES Act, which narrowly passed the lower chamber in mid-May. The $45 billion they’re promising may sound like a godsend to states staring at huge budget deficits in the wake of the recession caused by the coronavirus pandemic. But Medicaid ...
Commentary

The Savings Potential Of Biosimilars Is More Urgent Than Ever

It was not long ago that the economy’s rising tide was supporting state budgets across the country. As the Pew Charitable Trusts noted, widespread economic prosperity was supporting tax revenue growth and creating budget surpluses. When times are good, saving money is not always a priority in state capitols. But, times are ...
Commentary

Stop Calling Biden’s Radical Health Agenda ‘Moderate’

After a contentious primary, Joe Biden is the presumptive Democratic presidential nominee. Earlier this month, Sen. Bernie Sanders has finally endorsed Biden, and the rest of the party is falling in line. Biden largely succeeded by positioning himself as a middle-of-the-road alternative to Sen. Sanders and his brand of democratic socialism. But Biden’s ...
Blog

COVID-19 Reminds Us That Both Innovation and Affordability Are Needed

In her March 25 Forbes editorial, Sally Pipes documented how the private sector is rising to the health challenges of the coronavirus. Whether it is Moderna launching clinical trials for a COVID-19 vaccine or Gilead Sciences investigating whether one of its medicines, Remdesivir, is effective against the coronavirus, private sector ...
Commentary

Expand Medicaid? Democrats’ plan would increase waste, fraud and debt

If Democrats can’t get “Medicare-for-all,” it seems they’ll settle for “Medicaid-for-most.” Last month, the House of Representatives passed a bill that would supposedly “stabilize” ObamaCare by lavishing billions of dollars on Medicaid. To pay for that effort, the bill’s proponents envision cutting Medicare by nearly $450 billion over 10 years. Democrats are also lobbying states to expand the program to able-bodied, ...
Business & Economics

Basic Income Guarantees Would ‘Warehouse’ Poor, Not Propel Them

As Americans struggle to recover from a deep recession fueled by the COVID-19 crisis, and respond in horror to the violence in many communities following the death of George Floyd, economic inequality and lack of opportunity have risen to the top of the political discussion. Liberal voices like House Speaker ...
Commentary

Do coronavirus numbers show bias in health care? This study’s results will surprise you

African-Americans make up 12.4 percent of the population but have accounted for 23.8 percent of the nation’s COVID-19 deaths, as of June 23. This disparity has gained considerable attention in light of the protests sweeping the country. But the situation is more complicated than it appears. According to a working ...
Commentary

Democrats’ Obamacare Bailout Could Extend The Pandemic

This week, the House of Representatives is set to vote on legislation designed to “stabilize” Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic crisis. But the legislation would ...
Climate Change

Biden’s Mask Of Moderation Has Finally Slipped

Presumptive Democratic presidential nominee Joe Biden pitches himself to American voters as a reasonable and pragmatic centrist. But he’s stocked his campaign team with some of the Democratic party’s most prominent—and extreme—left-wingers. Last month, Biden announced the creation of several policy task forces designed to bring the party together. Those task ...
Commentary

COVID-19 Reveals The Power Of Deregulation

One of the most effective policy responses to COVID-19 thus far has not been a new government program or infusion of federal funding. Rather, it’s been the deliberate effort by the Trump administration to pare back regulations impeding access to health care. That work must continue after the pandemic passes. ...
Commentary

The coronavirus recession is no excuse for Medicaid expansion

House Democrats are looking to funnel billions of dollars into state Medicaid programs through the HEROES Act, which narrowly passed the lower chamber in mid-May. The $45 billion they’re promising may sound like a godsend to states staring at huge budget deficits in the wake of the recession caused by the coronavirus pandemic. But Medicaid ...
Commentary

The Savings Potential Of Biosimilars Is More Urgent Than Ever

It was not long ago that the economy’s rising tide was supporting state budgets across the country. As the Pew Charitable Trusts noted, widespread economic prosperity was supporting tax revenue growth and creating budget surpluses. When times are good, saving money is not always a priority in state capitols. But, times are ...
Commentary

Stop Calling Biden’s Radical Health Agenda ‘Moderate’

After a contentious primary, Joe Biden is the presumptive Democratic presidential nominee. Earlier this month, Sen. Bernie Sanders has finally endorsed Biden, and the rest of the party is falling in line. Biden largely succeeded by positioning himself as a middle-of-the-road alternative to Sen. Sanders and his brand of democratic socialism. But Biden’s ...
Blog

COVID-19 Reminds Us That Both Innovation and Affordability Are Needed

In her March 25 Forbes editorial, Sally Pipes documented how the private sector is rising to the health challenges of the coronavirus. Whether it is Moderna launching clinical trials for a COVID-19 vaccine or Gilead Sciences investigating whether one of its medicines, Remdesivir, is effective against the coronavirus, private sector ...
Scroll to Top